Bernard Broermann Net Worth

Bernard Broermann, born in 1943 in Koenigstein, Germany, founded Asklepios Kliniken GmbH in 1984, which has since become one of the three largest operators of private hospitals in Germany. The group has expanded its footprint through acquisitions and equity investments, and holds a 17.57% stake in Rhoen Klinikum AG and a majority stake in mediClin AG. Broermann also owns several luxury hotels, including the five-star Hotel Atlantic Kempinski in Hamburg, the Falkenstein Grand Kempinski in Koenigstein, and the Villa Rothschild Kempinski near Frankfurt. These hotels have proven to be a successful means of attracting foreign patients to Asklepios' medical clinics.
Bernard Broermann is a member of Health care

Age, Biography and Wiki

Birth Year 1943
Birth Place Koenigstein, Germany, Germany
Age 80 YEARS OLD
Residence Königstein, Germany
Alma mater Harvard University, INSEAD
Occupation Founder, Asklepios Kliniken
Spouse(s) married
Children 3

💰 Net worth: $4.8 Billion (2024)

Bernard Broermann, a prominent figure in the healthcare industry in Germany, is currently estimated to have a net worth of $4.8 billion by 2024. With his extensive knowledge and experience, he has made remarkable contributions to the healthcare sector, revolutionizing patient care in the country. Broermann's success can be attributed to his visionary leadership as the founder and CEO of a leading healthcare organization. Through his entrepreneurial endeavors, he has not only amassed significant wealth but has also played a pivotal role in shaping Germany's healthcare landscape, ultimately improving the well-being of countless individuals.

2009 $2.4 Billion
2010 $3.4 Billion
2011 $2.1 Billion
2012 $2.1 Billion
2013 $2.1 Billion
2014 $2.8 Billion
2015 $2.7 Billion
2016 $4.3 Billion
2017 $3.3 Billion
2018 $4.92 Billion

Biography/Timeline

1984

Broermann worked as an accountant and Lawyer before founding Asklepios and his first hospital in 1984.

2015

As of November 2015, Forbes estimated his net worth at US$2.9 billion.